Controlled double-blind comparative trial with fluprednylidene acetate cream and its base

Area of Science:

• Dermatology
• Pharmacology

Background:

• Corticosteroid creams are standard treatments for various skin diseases.
• Optimizing corticosteroid therapy aims to maximize efficacy while minimizing side effects and usage.

Purpose of the Study:

• To evaluate the efficacy and safety of a combined therapy regimen for corticoid-responsive skin diseases.
• To compare a novel treatment approach using fluprednylidene acetate cream with a standard cream base against existing corticosteroid treatments.

Main Methods:

• A controlled, double-blind, contralateral study was conducted on 31 inpatients.
• The combined therapy involved fluprednylidene acetate cream (once daily) plus its cream base (twice daily).
• This was compared to fluprednylidene acetate cream (three times daily) and betamethasone 17-valerate cream (three times daily).

Main Results:

• The combined therapy demonstrated comparable therapeutic results (good to very good) to both fluprednylidene acetate (three times daily) and betamethasone 17-valerate creams over a 15-day period.
• No adverse side effects were reported during the trial.
• The treatment efficacy was consistently good across all tested regimens.

Conclusions:

• Combined therapy with fluprednylidene acetate cream and its cream base offers an effective treatment option for corticoid-responsive dermatoses.
• This regimen allows for reduced corticosteroid application, potentially lowering treatment risks.
• The approach provides a flexible therapeutic strategy adaptable to individual patient needs.